Companies / Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc.

Nasdaq: MISTCanadaCIK 1408443MONTREAL, Canada

Financials

Revenue
Net income$-63.06M
Total debt$59.21M
Cash$169.73M
Diluted EPS$-0.75
Shares outstanding124.5M

Ownership

124.5M shares outstanding · as of Aug 12, 2026
0.76%Insiders
Ownership
Insiders0.76%951,027
10%+ / strategic7.28%9,067,848
Institutions23.73%29,549,409
Public float68.22%84,929,696

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 7

View all →
Insider% of sharesShares
Oliveto JosephCEOPresident and CEO · Director
0.39%482,744
Muller LorenzChief Commercial Officer
0.16%205,406
Bharucha DavidChief Medical Officer
0.09%113,181
Hasija AmitCFO & EVP of Corp. Development
0.08%99,848
Nelson Jeffrey EdwardChief Operating Officer
0.04%49,848
Sandoval David I.GC & Chief Compliance Officer

Institutional holders 85

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Dec 15, 2025Oliveto Joseph
CEO
SellCommon Shares$308.7K-133K
-22.79%
450,667
0.36% of shares
medium
Dec 15, 2025Hasija Amit
Executive
SellCommon Shares$134.6K-58K
-38.67%
91,993
0.07% of shares
medium
Dec 15, 2025Nelson Jeffrey Edward
Executive
SellCommon Shares$134.6K-58K
-58.01%
41,993
0.03% of shares
medium
Dec 15, 2025Bharucha David
Executive
SellCommon Shares$134.6K-58K
-35.51%
105,326
0.08% of shares
medium
Dec 15, 2025Muller Lorenz
Executive
SellCommon Shares$124.3K-54K
-21.42%
196,486
0.16% of shares
medium
Jan 8, 2026Oliveto Joseph
CEO
SellCommon Shares$96.8K-43K
-12.40%
303,721
0.24% of shares
low
Jan 26, 2026Oliveto Joseph
CEO
SellCommon Shares$66.6K-35K
-6.67%
482,744
0.39% of shares
low
Jan 26, 2026Hasija Amit
Executive
SellCommon Shares$23.6K-12K
-10.92%
99,848
0.08% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Pavaki Capital Management LLCPassive13G9,067,848
Trails Edge Capital Partners, LPPassive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
MIST59935V107